Revance Therapeutics
(NASDAQ) RVNC
Revance Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$247.00M
Net Income (TTM)
$181.44M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
RVNC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Revance Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
597
CEO
Mark J. Foley
Website
www.revance.comHeadquarters
Nashville, TN 37203, US
RVNC Financials
Key Financial Metrics (TTM)
Gross Margin
35%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
5%
Return on Capital
-81%
Return on Assets
-68%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$81.88M
Operating Income
$316.78M
EBITDA
$290.64M
Operating Cash Flow
$216.57M
Capital Expenditure
$6.89M
Free Cash Flow
$223.46M
Cash & ST Invst.
$253.91M
Total Debt
$478.43M
Revance Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$59.88M
+5.5%
Gross Profit
$42.25M
+13.1%
Gross Margin
70.55%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
597
N/A
Net Income
$35.12M
+75.1%
EBITDA
$28.63M
+10.3%
Quarterly Fundamentals
Net Cash
$299.37M
-46.1%
Accounts Receivable
$48.26M
+89.9%
Inventory
$85.21M
+84.4%
Long Term Debt
$456.08M
-2.8%
Short Term Debt
$27.36M
-23.5%
Return on Assets
-67.72%
N/A
Return on Invested Capital
-81.39%
N/A
Free Cash Flow
$41.15M
+25.8%
Operating Cash Flow
$41.09M
+19.4%